Structures of an MHC class II molecule with covalently bound single peptides
about
Structure of a complex of the human alpha/beta T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and alloreactivTom20 recognizes mitochondrial presequences through dynamic equilibrium among multiple bound statesIdentification of HLA-DRPhebeta47 as the susceptibility marker of hypersensitivity to beryllium in individuals lacking the berylliosis-associated supratypic marker HLA-DPGlubeta69.Human leukocyte antigen class II associations with hepatitis C virus clearance and virus‐specific CD4 T cell response among Caucasians and African AmericansStructure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetesStructural Basis of Cytochrome c Presentation by IE kAlternate interactions define the binding of peptides to the MHC molecule IA(b).Zinc Induces Dimerization of the Class II Major Histocompatibility Complex Molecule That Leads to Cooperative Binding to a SuperantigenThe structure of HLA-DR52c: Comparison to other HLA-DRB3 allelesStructure of a TCR with high affinity for self-antigen reveals basis for escape from negative selectionCrystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic proteinGenetic structure and contrasting selection pattern at two major histocompatibility complex genes in wild house mouse populationsDetermining the breadth of the respiratory syncytial virus-specific T cell responseRous-Whipple Award Lecture. Chemical features of peptide selection by the class II histocompatibility molecules.3D analysis of the TCR/pMHCII complex formation in monkeys vaccinated with the first peptide inducing sterilizing immunity against human malaria.Human leukocyte antigen-DQ8 transgenic mice: a model to examine the toxicity of aerosolized staphylococcal enterotoxin BThe binding of antigenic peptides to HLA-DR is influenced by interactions between pocket 6 and pocket 9.Synthetic peptide vaccines effective in preventing virus infection.Manipulating antigenic ligand strength to selectively target myelin-reactive CD4+ T cells in EAE.Establishment of latent Epstein-Barr virus infection and stable episomal maintenance in murine B-cell lines.Energetic asymmetry among hydrogen bonds in MHC class II*peptide complexes.Paradoxical intrathymic positive selection in mice with only a covalently presented agonist peptideTwo distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor 1, and transforming growth factor betaThe polysaccharide portion of lipopolysaccharide regulates antigen-specific T-cell activation via effects on macrophage-mediated antigen processing.Dissociation of peripheral T cell responses from thymocyte negative selection by weak agonists supports a spare receptor model of T cell activation.Distinct recognition by two subsets of T cells of an MHC class II-peptide complex.Interpretation of biphasic dissociation kinetics for isomeric class II major histocompatibility complex-peptide complexes.Function-related regulation of the stability of MHC proteins.Induction of dominant transplantation tolerance by an altered peptide ligand of the male antigen Dby.Flanking residues are central to DO11.10 T cell hybridoma stimulation by ovalbumin 323-339.HLA-DM targets the hydrogen bond between the histidine at position beta81 and peptide to dissociate HLA-DR-peptide complexes.Binding interactions between peptides and proteins of the class II major histocompatibility complex.Differential binding of pyruvate dehydrogenase complex-E2 epitopes by DRB1*08:01 and DRB1*11:01 Is predicted by their structural motifs and correlates with disease risk.Identification of an I-Ed-restricted T-cell epitope of Escherichia coli outer membrane protein F.A small number of residues in the class II molecule I-Au confer the ability to bind the myelin basic protein peptide Ac1-11Molecular dynamics simulations to provide insights into epitopes coupled to the soluble and membrane-bound MHC-II complexes.The lack of consensus for I-A(g7)-peptide binding motifs: is there a requirement for anchor amino acid side chains?Fusion-protein-assisted protein crystallizationStability of empty and peptide-loaded class II major histocompatibility complex molecules at neutral and endosomal pH: comparison to class I proteins.Systemic immunomodulation of autoimmune disease using MHC-derived recombinant TCR ligands
P2860
Q24673986-95EDA56C-E1B0-46A9-BA7D-DC93261ECB22Q24676372-6820295B-EBBD-469B-A95E-97748EF0E45FQ24811040-5F54687D-C555-44A0-ACF7-5E3E9845195BQ27489728-60D1B280-8338-4E5E-B5DF-047576726C6BQ27632133-52A81082-C6AA-4694-94FE-BEAD533FE5B9Q27638866-DED1BB94-3CC0-4399-95B2-1DA5B2324015Q27639260-D446C41C-ECE4-41A3-9C77-B7AB232BA4D0Q27640743-53A96BA1-ABB9-4629-862C-74714E759D3BQ27651531-68966788-0D37-4460-9137-C041C09262DBQ27666863-86D38AD4-59A8-4EBC-B2F2-6868EE7BCA61Q27765717-7FB4C196-2565-4B65-B05E-8E253FF1EB4BQ28744275-71F5E9D7-4447-417C-86C2-B44FD05EEAFCQ30411070-59DC952D-B1E3-42EB-B050-4F2CBFE62292Q33541540-5EEA6F23-AE43-4B26-9595-B005509A8CF4Q33545251-132656FE-E3E0-4592-A562-643C7103FECEQ33769260-75338163-1D03-474C-8D5E-6B989819C70BQ33772455-E4074715-A1D5-4D0C-BF62-DCF25F48EFD4Q33786753-4DCF1294-2CD3-47CE-A819-91DDFCF209F4Q33838467-1D48B21C-7005-4267-9277-54C9BD0851EDQ33866311-4D459D6D-D512-4D1B-B2E0-C5B0C63D7ED2Q33930509-A7FEAA2E-5529-4387-AF5C-0E871DABA658Q33930556-A9EB13C4-4D47-4398-B9BB-9887BCFEFCADQ33957154-47CDF37C-27C1-48A4-A734-8B4DBD1DC4B4Q34000037-69C6CFE5-2170-4867-92EB-894496AFA1CFQ34048781-40931DAD-544A-4EDC-981C-73D17949EADBQ34066093-ACA4C492-627D-4315-93DD-D7FAFDC0B7C1Q34171654-333D355D-59C4-4E71-BCE7-42E2E8A01A25Q34174199-8CFDA556-8D4F-464D-87FD-B22F1435F111Q34380578-0BEA94E0-8F31-43F1-B6E2-C2FB23DF9F21Q34460478-3CF13AAC-421B-4406-842B-C4044DF0F9E0Q34483195-79C73B8F-CF7B-4CE2-8C04-7E09855A58BDQ34540061-BCCA2602-B621-4065-A3C6-4460C2E4838FQ34643140-1DC42FB6-EAC4-4511-9196-CDB4B83ED747Q34756687-F6634B25-F9AB-4721-9089-714A5481B653Q34798966-E20D03BF-70B6-4C58-9A7C-12DF8A76F47BQ34973944-8B193080-AF27-4E27-82B0-DFD341E45EF0Q35557870-2A56B30C-1F59-42F3-AFFD-E2754D522454Q35841518-A8270614-D136-4315-BA6A-4B780A392478Q36048493-328975C4-9EB5-4C7F-B074-9C942E9EA7EDQ36107636-A2195C87-6BE1-4013-8272-0C656F1ED2FB
P2860
Structures of an MHC class II molecule with covalently bound single peptides
description
1996 nî lūn-bûn
@nan
1996 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Structures of an MHC class II molecule with covalently bound single peptides
@ast
Structures of an MHC class II molecule with covalently bound single peptides
@en
Structures of an MHC class II molecule with covalently bound single peptides
@nl
type
label
Structures of an MHC class II molecule with covalently bound single peptides
@ast
Structures of an MHC class II molecule with covalently bound single peptides
@en
Structures of an MHC class II molecule with covalently bound single peptides
@nl
prefLabel
Structures of an MHC class II molecule with covalently bound single peptides
@ast
Structures of an MHC class II molecule with covalently bound single peptides
@en
Structures of an MHC class II molecule with covalently bound single peptides
@nl
P2093
P1433
P1476
Structures of an MHC class II molecule with covalently bound single peptides
@en
P2093
D H Fremont
W A Hendrickson
P304
P356
10.1126/SCIENCE.272.5264.1001
P407
P577
1996-05-17T00:00:00Z